Immune dysregulation as a cause for allergic asthma

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 1, 1999, Pages 10-20

  Lipscomb, Mary F ^a   Wilder, Julie A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 9;

ANIMAL; ASTHMA; DISEASE MODEL; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; LUNG; RESPIRATORY TRACT INFECTION; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-13; INTERLEUKIN-9; LUNG; POLYMORPHISM, GENETIC; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 0032600479     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199901000-00003     Document Type: Article

References (115)

1. Doull IJM, Lawrence S, Watson M, Begishvilli T, Beasley RW, Lampe F, et al.: Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996, 153:1280-1284.
2. Noguchi E, Shibasaki M, Arinami T, Takeda K, Maki T, Miyamoto et al.: Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population. Am J Respir Crit Care Med 1997, 156:1390-1393.
3. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
4. Romagnani S: Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994, 6:838-846.
5. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler W, Presky DH: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998, 16:495-521.
6. Wu HY, Russell MW: Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res 1997, 16:187-201.
7. Forsthuber T, Yip HC, Lehmann PV: Induction of Th1 and Th2 immunity in neonatal mice. Science 1996, 271:1728-1730.
8. Daser A, Meissner N, Herz U, Renz H: Role and modulation of T-cell cytokines in allergy. Curr Opin Immunol 1995, 7:762-770.
9. Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul WE: Role of NK1.1+T cells in a Th2 response and in immunoglobulin E production. Science 1995, 270:1845-1847.
10. -T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice. J Immunol 1997, 158:5698-5706.
11. Takeuchi M, Alard P, Streilein JW: TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 1998, 160:1589-1597.
12. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H: Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature 1995, 373:255-257.
13. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, et al.: Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 1998, 391:177-181.
14. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997, 158:3539-3544.
15. Miadonna A, Gibelli S, Lorini M, Tedeschi A, Oddera S, Rossi GA, Crimi E: Expression of cytokine mRNA in bronchoalveolar lavage cells from atopic asthmatics before late antigen-induced reaction. Lung 1997, 175:195-209.
16. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR: Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997, 156:704-708.
17. Shaver JR, Zangrilli JG, Cho S, Cirelli RA, Pollice M, Hastie AT, et al.: Kinetics of the development and recovery of the lung from IgE-mediated inflammation. Am J Respir Crit Care Med 1997, 155:442-448.
18. Hallstrand TS, Ault KA, Bates PW, Mitchell J, Schoene RB: Peripheral blood manifestations of Th2 lymphocyte activation in stable atopic asthma and during exercise-induced bronchospasm. Ann Allergy Asthma Immunol 1998, 80:424-432.
19. Lara-Marquez ML, Deykin A, Krinzman S, Listman J, Israel E, He H, et al.: Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. J Allergy Clin Immunol 1998, 101:699-708.
20. van der Pouw Kraan TC, Boeije LC, de Groot ER, Stapel SO, Snijders A, Kapsenberg ML, et al.: Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol 1997, 158:5560-5555.
21. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF: T cells subsets and cytokines in allergic and non-allergic children: II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine 1997, 9:427-436.
22. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF: T cell subsets and cytokines in allergic and non-allergic children: I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine 1997, 9:416-426.
23. Lantero S, Sacco O, Scala C, Rossi GA: Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF. J Asthma 1997, 34:141-152.
24. Nurse B, Haus M, Puterman AS, Weinberg EG, Potter PC: Reduced interferon-gamma but normal IL-4 and IL-5 release by peripheral blood mononuclear cells from Xhosa children with atopic asthma. J Allergy Clin Immunol 1997, 100:662-668.
25. Leonard C, Tormey V, Burke C, Poulter LW: Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am J Respir Cell Mol Biol 1997, 17:368-375. Eighteen atopic asthmatic people were stratified by symptom score and compared with six atopic nonasthmatics and seven healthy nonatopic volunteers. The article confirms earlier reports of increased interleukin-4 secretion by peripheral blood cells following allergen stimulation but was important in additionally showing that increasing asthma symptom scores correlated with decreasing interferon gamma production and a decreasing interferon gamma/interleukin-4 secretion ratio. These observations, similar to those of Nurse et al. (J Allergy Clin Immunol 1997, 100:662-668), raise the important possibility that the potential for T cells to maintain interferon gamma production to offset excess interleukin-4 secretion may be a marker for being capable of controlling Th2 mediated pulmonary inflammation.
26. Leonard C, Tormey V, Burke C, Poulter LW: Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am J Respir Cell Mol Biol 1997, 17:368-375. Eighteen atopic asthmatic people were stratified by symptom score and compared with six atopic nonasthmatics and seven healthy nonatopic volunteers. The article confirms earlier reports of increased interleukin-4 secretion by peripheral blood cells following allergen stimulation but was important in additionally showing that increasing asthma symptom scores correlated with decreasing interferon gamma production and a decreasing interferon gamma/interleukin-4 secretion ratio. These observations, similar to those of Nurse et al. (J Allergy Clin Immunol 1997, 100:662-668), raise the important possibility that the potential for T cells to maintain interferon gamma production to offset excess interleukin-4 secretion may be a marker for being capable of controlling Th2 mediated pulmonary inflammation.
27. O'Brien RM, Byron KA, Varigos GA, Thomas WR: House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes. Clin Exp Allergy 1997, 27:46-51.
28. Zurawski G, de Vries JE: Interleukin 13, an interleukin 4 like cytokine that acts on monocytes and B cells, not on T cells. Immunol Today 1994, 15:19-26.
29. Van der Pouw Kraan TC, Van der Zee JS, Boeije LC, De Groot ER, Stapel SO, Aarden LA: The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol 1998, 111:129-135.
30. Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD: IL-13, IL-4Rα and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998, 8:255-264.
31. Gauchat JF, Schlagenhauf E, Feng NP, Moser R, Yamage M, Jeannin P, et al.: A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 1997, 27:971-978.
32. Naseer T, Minshall EM, Leung DYM, Laberge S, Ernst P, Martin RJ, Hamid Q: Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997, 155:845-851.
33. Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, Kiser MB, Dragwa CR, et al.: Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A 1997, 94:13175-13180. A possible role for upregulation of interleukin-9 expression in predisposing to asthma was supported by qualitative trait locus mapping in inbred unimmunized C57BL/6 (B6) mice which show decreased AHR in response to the drug atricurium compared with hyperresponsive DBA/2 (D2) mice. Interleukin-9 mRNA expression in the lungs and in splenocytes following Con A stimulation was markedly reduced in the atricurium hyporesponsive B6 mice compared with the hyperresponsive D2 mice, Interestingly, splenocytes from BDF1 mice, which are intermediate in hyperresponsiveness, demonstrated intermediate levels of interleukin-9 expression, and cloned cells demonstrated that the B6 message was significantly less abundant than were the D2 message suggesting, a cis-acting element in the B6 locus that resulted in decreased induction of the gene.
34. Godfraind C, Louahed J, Faulkner H, Vink A, Warnier G, Grencis R, Renauld JC: Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol 1998, 160:3989-3996.
35. Burastero SE, Crimi E, Balbo A, Vavassori M, Borgonovo B, Gaffi D, et al.: Oligoclonality of lung T lymphocytes following exposure to allergen in asthma. J Immunol 1995, 155:5836-5846.
36. + T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol 1998, 112:1-9.
37. Yurovsky VV, Weersink EJ, Meltzer SS, Moore WC, Postma DS, Bleecker ER, White B: T-cell repertoire in the blood and lungs of atopic asthmatics before and after ragweed challenge. Am J Respir Cell Mol Biol 1998, 18:370-383.
38. Bergmann RL, Edenharter G, Bergmann KE, Guggenmoos-Holzmann I, Forster J, Bauer CP, et al.: Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy 1997, 27:752-760.
39. Nickel R, Kulig M, Forster J, Bergmann R, Bauer CP, Lau S, et al.: Sensitization to hen's egg at the age of twelve months is predictive for allergic sensitization to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol 1997, 99:613-617.
40. Sandford A, Weir T, Paré P: The genetics of asthma. Am J Respir Crit Care Med 1996, 153:1749-1765.
41. Barnes KC, Marsh DG: The genetics and complexity of allergy and asthma. Immunol Today 1998, 19:325-332.
42. Moffatt MF, Cookson WOCM: Linkage and candidate gene studies in asthma. Am J Respir Crit Care Med 1997, 156(suppl):S110-S112.
43. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich KE, et al.: Linkage analysis of IL-4 and other chromosome 5q31.1 marker and total serum immunoglobulin E concentrations. Science 1993, 264:1152-1156.
44. Postma D, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, et al.: Genetic susceptibility to asthma-bronchial hyperresponsiveness coin-herited with a major gene for atopy. N Engl J Med 1995, 333:894-900.
45. Laitinen T, Kauppi P, Ignatius J, Ruotsalainen T, Daly MJ, Kaariainen H, et al.: Genetic control of serum IgE levels and asthma: linkage and linkage disequilibrium studies in an isolated population. Hum Mol Genet 1997, 6:2069-2076.
46. Mansur AH, Bishop DT, Markham AF, Britton J, Morrison JF: Association study of asthma and atopy traits and chromosome 5q cytokine cluster markers. Clin Exp Allergy 1998, 28:141-150.
47. Kamitani A, Wong ZY, Dickson P, van Herwerden L, Raven J, Forbes AB, et al.: Absence of genetic linkage of chromosome 5q31 with asthma and atopy in the general population. Thorax 1997, 52:816-817.
48. Song S, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ: Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 1996, 156:424-429.
49. Shirakawa T, Li A, Bubowitz M, Dekker JW, Shaw ARE, Faux JA, et al.: Association between atopy and variant of the b subunit of the high affinity immunoglobulin E receptor. Nat Genet 1994, 7:125-130.
50. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, et al.: A genome-wide search for quantitative trait loci underlying asthma. Nature 1996, 383:247-250.
51. Hershey GKK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA: The association of atopy with a gain-of-functton mutation in the a subunit of the interleukin-4 receptor. N Engl J Med 1997, 337:1720-1725. This was a very important paper showing a dominant effect of the R576 allele of interleukin-R receptor a chain on the presence of atopy as defined by either the hyper IgE syndrome, severe atopic dermatitis, levels of IgE above 95 IU/ml, or a positive radioimmunosorbent test in response to common inhalant allergens. A point mutation at amino acid residue 576 in which a glutamine was replaced by an arginine was significantly increased in affected individuals compared with nonaffected controls. As a measure of the hyperfunctioning of the mutant receptor, B cells from wild-type and homozygous or heterozygous individuals were stimulated with interleukin-4, and CD23 on their B cells was measured. The level of CD23 expression was higher on those bearing the R576 allele. Finally, regulation of signaling was altered in those with the R576 allele and associated with a change in the binding specificity of the adjacent tyrosine residue at position 575 to Stat-6 versus SHP-1. Although the presence or absence of asthma was not discussed, this article has implications for regulation of IgE production highly associated with atopic asthma.
52. Cookson WOCM, Moffatt MF: Asthma: An epidemic in the absence of infection. Science 1997, 275:41-42.
53. Pisetsky DS: Immunostimulatory DNA: A clear and present danger? Nat Med 1997, 3:829-831.
54. Rook GAW, Stanford JL: Give us this day our daily germs. Immunol Today 1998, 19:113-116.
55. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE: Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998, 157:1708-1720.
56. Silverman M: BCG vaccination and atopy: unfinished business? Lancet 1997, 350:380-381.
57. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM: The inverse association between tuberculin responses and atopic disorder [see comments]. Science 1997, 275:77-79. This provocative article perhaps more than any other has focused recent epidemiologic studies and research in experimental animal models on examining the role for certain early childhood infections in protection against asthma. Japanese children who had positive PPDs that persisted until age 12 years had a lower incidence of asthma and other atopic symptoms: lower serum IgE; lower serum interleukin-4, interleukin-13, and interleukin-10; and higher serum interferon gamma than non-PPD responders or PPD responders at age 6 years who converted to a negative PPD by age 12 years. Because all children had received BCG and had equivalent exposures to Mycobacteria tuberculosis as measured by PPD responses in family members and had similar exposure to allergens and familial histories of atopy, the conclusion was that exposure to the infectious agent with a persisting Th1 response was the reason for protection against atopy and asthma.
58. Shaheen SO, Aaby P, Hall AJ, Barker DJP, Heyes CB, Shiell AW, Goudiaby A: Measles and atopy in Guinea-Bissau. Lancet 1996, 347:1792-1796.
59. + T cell profile from Th2-dominant type to Th1-dominant type after varicella-zoster virus infection in atopic dermatitis. J Allergy Clin Immunol 1997, 100:274-281.
60. Roman M, Martin-Orozco E, Goodman JS, Nguyen M, Sato Y, Ronaghy A, et al.: Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997, 3:849-854.
61. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997, 186:1623-1631.
62. Auci DL, Kleiner GI, Chice SM, Athanassiades TJ, Dukor P, Durkin HG: Control of IgE responses: V. Oral administration of a synthetic derivative of the inner bacterial cell wall (SDZ 280.636) to sensitized mice induces isotype specific suppression of peak hapten specific IgE antibody forming cell responses, serum IgE levels and immediate hypersensitivity responses. Immunol Invest 1998, 27:105-120.
63. Rager KJ, Langland JO, Jacobs BL, Proud D, Marsh DG, Imani F: Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J Virol 1998, 72:1171-1176.
64. Alm JS, Lilja G, Pershagen G, Scheynius A: Early BCG vaccination and development of atopy. Lancet 1997, 350:400-403.
65. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998, 160:2555-2559. This article describes a mouse model for asthma in which unmethylated CpG dinucleotides previously shown to enhance a Th1 response were coadministered with the immunizing antigen. This measure protected against the development of airway eosinophiia, Th2 cytokine induction, IgE production, and AHR. Furthermore, in a previously sensitized mouse, CpG oligodeoxynucleotides also prevented airway inflammation following airway challenge with the antigen. Although driving a strong Th1 response using CpG dinucleotides might have negative effects in the production of Th1-mediated autoimmune diseases, this article was important in demonstrating the possibility of using these bacterial products in therapy for atopic diseases.
66. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G: Infection of mice with mycobacterium bovis-bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998, 187:561-569.
67. Glezen WP: Role of respiratory tract infection in childhood asthma: two views. In RSV and Asthma: Is There a Link? Edited by Hiatt PW. ATS Continuing Education Monograph Series. New York: American Thoracic Society; 1998:1-5.
68. Welliver RC: The role of RSV IgE in recurrent wheezing and asthma. In RSV and Asthma: Is There a Link? Edited by Hiatt PW. ATS Continuing Education Monograph Series. New York: American Thoracic Society; 1998:21-27.
69. Lemanske Jr. RF: Immunologic mechanisms in RSV-related allergy and asthma. In RSV and Asthma: Is There a Link? Edited by Hiatt PW. ATS Continuing Education Monograph Series. New York: American Thoracic Society; 1998:11-16.
70. Casillas AM, Nel AE: An update on the immunopathogenesis of asthma as an inflammatory disease enhanced by environmental pollutants. Allergy Asthma Proc 1997, 18:227-233.
71. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A: Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 1997, 158:2406-2413.
72. Harkema JR, Hotchkiss JA, Griffith WC: Mucous cell metaplasia in rat nasal epithelium after a 20-month exposure to ozone: a morphometric study of epithelial differentiation. Am J Respir Cell Mol Biol 1997, 16:521-530.
73. Seymour BW, Pinkerton KE, Friebertshauser KE, Coffman RL, Gershwin LJ: Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy. J Immunol 1997, 159:6169-6175. This may be the first publication demonstrating a role for second-hand smoke in the immune dysregulation that characterizes asthma, a relationship suspected from epidemiologic studies in humans. Although the mice received intraperitoneal priming to induce a systemic Th2 response, still it seems that the aerosol cigarette exposure enhanced the subsequent local Th2 response.
74. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K: Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997, 186:1737-1747.
75. Temann UA, Prasad B, Gallup MW, Basbaum C, Ho SB, Flavell RA, Rankin JA: A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997, 16:471-478.
76. Blyth DI, Pedrick MS, Savage TJ, Bright H, Beesley JE, Sanjar S: Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am J Respir Cell Mol Biol 1998, 19:38-54.
77. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, Hamid Q: Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997, 17:326-333.
78. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B: Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma. J Clin Invest 1998, 101:2129-2139.
79. Akimoto T, Numata F, Tamura M, Takata Y, Higashida N, Takashi T, et al.: Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med 1998, 187:1537-1542.
80. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ: Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998, 187:939-948.
81. Persson CG, Erjefalt JS, Korsgren M, Sundler F: The mouse trap. Trends Pharmacol Sci 1997, 18:465-467.
82. Vargraftig BB: Modifications of experimental bronchopulmonary hyperresponsiveness. Am J Respir Crit Care Med 1997, 156(suppl):S97-102.
83. Gleich GJ, Kita H: Bronchial asthma: lessons from murine models [comment]. Proc Natl Acad Sci U S A 1997, 94:2101-2102.
84. de Siqueira AL, Russo M, Steil AA, Facincone S, Mariano M, Jancar S: A new murine model of pulmonary eosinophilic hypersensitivity: contribution to experimental asthma. J Allergy Clin Immunol 1997, 100:383-388.
85. Kung TT: Pulmonary eosinophilia and inflammation in allergic mice. Lab Anim Sci 1998, 48:61-63.
86. Pauwels RA, Brusselle GJ, Kips JC: Cytokine manipulation in animal models of asthma. Am J Respir Crit Care Med 1997, 156(suppl):S78-81.
87. Stelts D, Egan RW, Falcone A, Garlisi CG, Gleich GJ, Kreutner W, et al.: Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol 1998, 18:463-470.
88. Garlisi CG, Falcone A, Hey JA, Paster TM, Fernandez X, Rizzo CA, et al.: Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation. Am J Respir Cell Mol Biol 1997, 17:642-651.
89. Minshall EM, Dandurand RJ, Hamid Q, Eidelman DH: Local cytokine messenger ribonucleic acid expression and in vitro allergic late phase responses in Brown-Norway rats. Eur Respir J 1998, 11:630-635.
90. Schneider T, van Velzen D, Moqbel R, Issekutz AC: Kinetics and quantitation of eosinophil and neutrophil recruitment to allergic lung inflammation in a brown norway rat model. Am J Respir Cell Mol Biol 1997, 17:702-712.
91. Renzi PM, Sebastiao N, Al Assaad A, Giaid A, Hamid Q: Inducible nitric oxide synthase mRNA and immunoreactivity in the lungs of rats eight hours after antigen challenge. Am J Respir Cell Mol Biol 1997, 17:36-40.
92. Watanabe A, Mishima H, Kotsimbos TC, Hojo M, Renzi PM, Martin JG, Hamid QA: Adoptively transferred late allergic airway responses are associated with the Th2-type cytokines in the rat. Am J Respir Cell Mol Biol 1997, 16:69-74.
93. Chin JE, Winterrowd GE, Hatfield CA, Brashler JR, Griffin RL, Vonderfecht SL, et al.: Involvement of intercellular adhesion molecule-1 in the antigen-induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 1998, 18:158-167.
94. Holt PG, Thomas JA: Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology 1997, 91:145-150.
95. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M: B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 1997, 158:2042-2049.
96. Oosterhout AJM, Hofstra CL, Shields R, Chan B, Van Ark I, Jardieu PM, Nijkamp FP: Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1997, 17:386-392.
97. Padrid PA, Mathur M, Li X, Herrmann K, Qin Y, Cattamanchi A, et al.: CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Respir Cell Mol Biol 1998, 18:453-462.
98. Keane-Myers AM, Gause WC, Finkelman FD, Xhou XD, Wills-Karp M: Development of murine allergic asthma is dependent upon B7-2 costimulation. J Immunol 1998, 160:1036-1043.
99. McMenamin C, Pimm C, McKersey M, Holt PG: Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994, 265:1869-1871.
100. van Halteren AG, van der Cammen MJ, Cooper D, Savelkoul HF, Kraal G, Holt PG: Regulation of antigen-specific IgE, IgG1, and mast cell responses to ingested allergen by mucosal tolerance induction. J Immunol 1997, 159:3009-3015.
101. Haneda K, Sano K, Tamura G, Sato T, Habu S, Shirato K: TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol 1997, 159:4484-4490.
102. Russo M, Jancar S, Pereira de Siqueira AL, Mengel J, Gomes E, Ficker SM, Caetano de Faria AM: Prevention of lung eosinophilic inflammation by oral tolerance. Immunol Lett 1998, 61:15-23.
103. Hogan SP, Foster PS, Charlton B, Slattery RM: Prevention of Th2-mediated murine allergic airways disease by soluble antigen administration in the neonate. Proc Natl Acad Sci U S A 1998, 95:2441 -2445.
104. Lambert AL, Winsett DW, Costa DL, Selgrade MK, Gilmour MI: Transfer of allergic airway responses with serum and lymphocytes from rats sensitized to dust mite. Am J Respir Crit Care Med 1998, 157:1991-1999.
105. Kaminuma O, Mori A, Suko M, Kikkawa H, Naito K, Okudaira H: Development of lung eosinophilic inflammation by the infusion of IL-5-producing T cell clones. Int Arch Allergy Immunol 1997, 114(suppl 1):10-13.
106. Danzig M, Cuss F: Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation. Allergy 1997, 52:787-794.
107. Hamelmann E, Oshiba A, Schwarze J, Bradley K, Loader J, Larsen GL, Gelfand EW: Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 1997, 16:674-682.
108. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998, 157:210-218.
109. Kaminuma O, Mori A, Ogawa K, Nakata A, Kikkawa H, Naito K, et al.: Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol 1997, 16:448-454.
110. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et al.: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997, 185:2143-2156.
111. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS: Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997, 99:1329-1339.
112. Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, Oettgen HC: Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma 5Bsee comments]. Proc Natl Acad Sci U S A 1997, 94:1344-1349.
113. Nagai H, Yamaguchi S, Maeda Y, Tanaka H: Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin Exp Allergy 1996, 26:642-647.
114. Hessel EM, Van Oosterhout AJ, Van Ark I, Van Esch B, Hofman G, Van Loveren H, et al.: Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Cell Mol Biol 1997, 16:325-334.
115. + factor or factors is responsible for AHR awaits discovery.